EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers

Sylviane Olschwang, Kai Yu, Christine Lasset, Stéphanie Baert-Desurmont, Marie-Pierre Buisine, Qing Wang, Pierre Hutter, Etienne Rouleau, Olivier Caron, Violaine Bourdon, Gilles Thomas

Journal of Cancer Epidemiology · 2009

DOI: 10.1155/2009/791754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Epidemiology, 2009. Verfasst von Sylviane Olschwang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 891, Centre de Recherches en Cancérologie de Marseille, 13009 Marseille, Fr…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Institut National Du Cancer, French Ministry of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lynch syndrome is mostly characterized by early-onset colorectal and endometrial adenocarcinomas. Over 90% of the causal mutations occur in two mismatch repair genes, MSH2 and MLH1 . The aim of this study was to evaluate the age-dependent cancer risk in MSH2 or MLH1 mutation carriers from data of DNA diagnostic laboratories. To avoid overestimation, evaluation was based on the age-dependent proportion of mutation carriers in asymptomatic first-degree relatives of identified mutation carriers. Data from 859 such eligible relatives were collected from 8 centers; 387 were found to have inherited the mutation from their relatives. Age-dependent risks were calculated either using a nonparametric approach for four discrete age groups or assuming a modified Weibull distribution for the dependence of risk on age. Cancer risk was estimated starting at 28 (25–32 0.68 confidence interval) and to reach near 0.70 at 70 years. The risks were very similar for MSH2 and MLH1 mutation carriers. Although not statistically significant, the risk in males appeared to precede that for females by ten years. This difference needs to be investigated on a larger dataset. If confirmed, this would indicate that the onset of the colonoscopic surveillance may be different in male and female mutation carriers.

Autor:innen und Institutionen

  • Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 891, Centre de Recherches en Cancérologie de Marseille, 13009 Marseille, France.

Förderung

  • Institut National Du Cancer
  • French Ministry of Health

Zitieren

APA

Olschwang, S., Yu, K., Lasset, C., Baert-Desurmont, S., Buisine, M. P., Wang, Q., Hutter, P., Rouleau, E., Caron, O., Bourdon, V., & Thomas, G. (2009). Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers. Journal of Cancer Epidemiology. https://doi.org/10.1155/2009/791754

Vancouver

Olschwang S, Yu K, Lasset C, Baert-Desurmont S, Buisine MP, Wang Q, et al. Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers. Journal of Cancer Epidemiology. 2009. doi:10.1155/2009/791754

BibTeX
@article{Olschwang2009,
  author = {Olschwang, Sylviane and Yu, Kai and Lasset, Christine and Baert-Desurmont, Stéphanie and Buisine, Marie-Pierre and Wang, Qing and Hutter, Pierre and Rouleau, Etienne and Caron, Olivier and Bourdon, Violaine and Thomas, Gilles},
  title = {Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers},
  journal = {Journal of Cancer Epidemiology},
  year = {2009},
  doi = {10.1155/2009/791754}
}
Kostenlos starten →